RARIN Wiki

Rarin (rarafin) in 1953, a broad-spectrum antibiotic called Rarin was introduced into the world market.  It was safe for children.  In the 70’s it was found that young teens who’d received the drug had an abnormally high incidence of babies without genitalia.  The deformity is recessive, so only children with two affected parents have it.    About 0.3% of children in the US are rarebits.

Rarin causes chromosomal damage to a significant number of pubescent youths who take it.  The damage affects the 23rd pair, but does not manifest itself in the initial generation.  Chromosomes affected are always the first of the pair (and X) which undergoes a change where the top two legs of the 'X' loop together, forming what is called an 'R' chromosome.

Rarin victims with this damage are called psuedos, with pseudomales having RY and pseudofemales having RX.  Children born to psuedos or psuedonormo pairs can be pseudos or rarebits (RR). 

One quarter of the offspring born to two psuedoparents are each rarebits, pseudomale, pseudofemale, or male.  When a male and psuedofemale breed, half of the children are normal and half are psuedo, but may be of either sex.  The offspring of a pseudomale and a female is either a psudofemale (1/2) or a male (1/2).

♀/♂	R	Y
R	RR	RY
X	RX	XY
pseudofemalepseudomale

♀/♂	X	Y
R	RX	RY
X	XX	XY
pseudofemale/male

♀/♂	R	Y
X	RX	XY
X	RX	XY
female/pseudomale

Rarin and generic rarafin (after 1965) were popular in certain parts of the world in the 60's and 70's because it was cheap and effective.  Rarin is effective against a large number of bacterial and fungal infections, and  in most systems of the body.  Most notably, it fights respiratory and blood-born pathogens.  It is not effective against topical, neurological, or gastro-intestinal diseases, but low doses (3-5 mg) boost the immune system and provide a certain preventative benefit against newly-acquired illnesses.  Rarin is ineffective against viral infections, but its immune mitigating effects can reduce the chances of getting them in the first place.

Rarin is administered in 3, 5, 10, and 20 mg tablets, which bear an 'Rr' on one side and a score line and the dosage on the other.  The are color coded as well; they come in robin's

egg blue (3 mg), pink (5 mg), lemon yellow (10 mg), and white (20 mg).

Rarifin, the active ingredient in Rarin, was first isolated from a mixture of three plant extracts that have been chewed and spat into a communal pit.  The enzyme action and subsequent chemical reaction synthesizes rarifin. 

The antibiotic reaction of this salve (called 'ragaga' in the local language) was first described by an attending US Army surgeon in 1907, but it was little-known and no effort to adapt it to medical use was made until 1929, during the Pacific War, when an antibiotic was needed for American soldiers and sailors who were allergic to penicillin.

To this day, the identity and location of the islands, as well as the plants and method of production, are closely guarded secrets.

Research was carried out on its efficacy and safety in adults, and in 1936 1% rarifin extract was made available to soldiers in a tincture of alcohol.  Poor quality control and the potential for abuse by combat soldiers led to its abandonment in 1940.

In 1945, President Truman asked the AMA to investigate rarifin as a possible medicine to reduce the spread of disease among US relief volunteers abroad.  Research resumed in 1946 and the following year, rarifin was first synthesized.  Animal testing (and a few humans) began in 1947 and continued until 1953.  Rats were the original subjects but soon rabbits were added to the tests.

In 1948, rarifin was patented by Martin Pharmaceuticals.  Testing in rats had produced no side-effects, but tests on rabbits revealed a 1% incidence of sterile females.  This was thought to be insignificant and testing began on a group of 12 human patients that same year.  Rat tests ceased in 1949, but the rabbit subjects were kept until 1951.

In 1952, just months before Rarin was approved by the FDA, research came to light that the sterile rarifin-rabbits were really genetic 'mules' with not sex organs at all.  As it had been tested on about 150 people in a wide demographic distribution and no ill effects had been noticed, the Martin board-of-directors decided to ignore the report and went ahead with its release in 1953.

Rarebit (Rabbit), a slang term for Rarin Baby.  Rarin babies have no primary or secondary sex characteristics; no internal or external genitalia, breasts, or even nipples.  They do not go through puberty, nor do they grow body hair, their voice doesn’t drop, and their brains continue to acquire language like a pre-pubescent child.

Rarebits are almost always classified as female at birth and most cases are not discovered until they begin their first gynecological exams sometime in their early teens.  Even as toddlers, as many as a half to a third of rarebits will reject their assigned gender roles, though mostly they are just reclassified by society as 'tomboys' or even 'potential lesbians'. 

The typical rarebit adult looks like a pre-pubescent girl of 12-14.  They have the mons venera and labia majora, but no clitoris, vagina, uterus or ovaries or labia minora.  There is often a blue patch or spot where the vaginal opening should be, and it looks somewhat like an imperforate hymen.

Rarebits do not have enlarged breasts, nipples, or areola.  For the most part, rarebits have no sexuality or sexual desires.  They do, however, have normal human emotions and can love, hate, desire, etc.; they are just not driven by floods of hormones.  Some rarebits do develop or retain gender identities from their environment, and a few have been known to become romantically involved.  Even in such cases, though, they don't develop a sexuality, in that they do not have a sex-driven attraction to primary and secondary sex characteristics. 

By the 80's and 90's, rarebits start developing a social sense of identity (as part of the GLBTO movement) and their own culture.  Some come together in pairs or, rarely, larger units but the relationship is purely platonic.  They do, however form close primary bonds in most such cases.  Their fight for legal rights parallels that of the GLBT community.

Rarebits have approximately equally low levels of various sex hormones and are not as prone to depression or mood swings.  Bipolar disorder and dissociative personality disorders are unknown in rarebits. 

Rarebits do, however, have a high incidence of social anxiety and rarely fit into normal society.  Even in the 80's and 90's the condition was largely unknown to the public and was classified as a birth defect or disease until 1998.

As late as the turn of the century, surgeries and hormone therapy were offered to 'cure' rarebitism.